Ethan Lange
Concepts (675)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 43 | 2016 | 940 | 3.770 |
Why?
| Genetic Linkage | 41 | 2012 | 321 | 3.330 |
Why?
| Polymorphism, Single Nucleotide | 64 | 2023 | 2062 | 3.210 |
Why?
| Genetic Predisposition to Disease | 65 | 2023 | 2275 | 3.040 |
Why?
| Genome-Wide Association Study | 44 | 2023 | 1323 | 2.800 |
Why?
| Genotype | 52 | 2023 | 1882 | 1.540 |
Why?
| Genome, Human | 17 | 2020 | 387 | 1.490 |
Why?
| Gene Frequency | 33 | 2022 | 513 | 1.450 |
Why?
| Genetic Variation | 25 | 2021 | 926 | 1.270 |
Why?
| Cardiovascular Diseases | 17 | 2022 | 1798 | 1.080 |
Why?
| Chromosomes, Human, Pair 17 | 11 | 2019 | 63 | 1.060 |
Why?
| Exome | 9 | 2016 | 220 | 0.970 |
Why?
| Haplotypes | 26 | 2016 | 473 | 0.870 |
Why?
| Chromosome Mapping | 25 | 2010 | 510 | 0.860 |
Why?
| Alleles | 20 | 2018 | 832 | 0.850 |
Why?
| Body Mass Index | 17 | 2022 | 2092 | 0.830 |
Why?
| Obesity | 15 | 2023 | 2746 | 0.810 |
Why?
| Genetic Loci | 10 | 2019 | 281 | 0.790 |
Why?
| Hypertension | 7 | 2022 | 1203 | 0.790 |
Why?
| Models, Genetic | 14 | 2022 | 595 | 0.770 |
Why?
| Male | 134 | 2023 | 57801 | 0.750 |
Why?
| Pedigree | 24 | 2016 | 485 | 0.690 |
Why?
| Middle Aged | 77 | 2023 | 27617 | 0.690 |
Why?
| Sickle Cell Trait | 4 | 2020 | 15 | 0.680 |
Why?
| Humans | 185 | 2023 | 118972 | 0.680 |
Why?
| Genetic Association Studies | 9 | 2022 | 371 | 0.660 |
Why?
| Polymorphism, Genetic | 9 | 2009 | 642 | 0.660 |
Why?
| Aged | 68 | 2023 | 19657 | 0.650 |
Why?
| Chromosomes, Human, Pair 8 | 5 | 2019 | 32 | 0.650 |
Why?
| Phenotype | 26 | 2021 | 3003 | 0.580 |
Why?
| Apolipoproteins E | 3 | 2015 | 90 | 0.580 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2015 | 47 | 0.550 |
Why?
| Adult | 72 | 2023 | 31512 | 0.540 |
Why?
| Female | 109 | 2023 | 61564 | 0.540 |
Why?
| Chromosomes, Human, Pair 11 | 11 | 2011 | 66 | 0.530 |
Why?
| Lipoprotein(a) | 1 | 2015 | 49 | 0.530 |
Why?
| Fibroblast Growth Factor 5 | 1 | 2015 | 2 | 0.530 |
Why?
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2015 | 10 | 0.520 |
Why?
| Diabetes Mellitus, Type 2 | 10 | 2023 | 2174 | 0.510 |
Why?
| Transferrin | 1 | 2014 | 39 | 0.510 |
Why?
| Trinucleotide Repeats | 2 | 2008 | 24 | 0.500 |
Why?
| Ferritins | 1 | 2014 | 61 | 0.500 |
Why?
| src-Family Kinases | 1 | 2015 | 90 | 0.490 |
Why?
| Receptors, Androgen | 3 | 2017 | 134 | 0.490 |
Why?
| Quantitative Trait, Heritable | 9 | 2021 | 119 | 0.490 |
Why?
| Anemia, Iron-Deficiency | 1 | 2014 | 56 | 0.480 |
Why?
| Quantitative Trait Loci | 9 | 2022 | 324 | 0.470 |
Why?
| Family Health | 10 | 2017 | 201 | 0.470 |
Why?
| Blood Pressure | 5 | 2020 | 1664 | 0.460 |
Why?
| Fibrin Fibrinogen Degradation Products | 2 | 2017 | 79 | 0.450 |
Why?
| Lod Score | 16 | 2011 | 75 | 0.440 |
Why?
| Iron | 1 | 2014 | 248 | 0.440 |
Why?
| Ataxia Telangiectasia | 10 | 2004 | 17 | 0.440 |
Why?
| Microsatellite Repeats | 11 | 2012 | 143 | 0.420 |
Why?
| Receptors, Urokinase Plasminogen Activator | 2 | 2021 | 14 | 0.400 |
Why?
| Blood Coagulation | 2 | 2015 | 219 | 0.400 |
Why?
| Cohort Studies | 22 | 2020 | 5116 | 0.390 |
Why?
| Control Groups | 1 | 2010 | 10 | 0.390 |
Why?
| Weight Gain | 5 | 2016 | 493 | 0.380 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2010 | 20 | 0.380 |
Why?
| Proteins | 7 | 2022 | 938 | 0.380 |
Why?
| Longitudinal Studies | 15 | 2022 | 2513 | 0.380 |
Why?
| Risk Factors | 25 | 2023 | 9000 | 0.370 |
Why?
| X Chromosome | 2 | 2000 | 47 | 0.370 |
Why?
| Genes, BRCA1 | 3 | 2004 | 31 | 0.360 |
Why?
| Costs and Cost Analysis | 1 | 2010 | 202 | 0.360 |
Why?
| Germ-Line Mutation | 6 | 2020 | 134 | 0.350 |
Why?
| C-Reactive Protein | 5 | 2020 | 360 | 0.350 |
Why?
| Malocclusion, Angle Class III | 1 | 2009 | 2 | 0.350 |
Why?
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2020 | 59 | 0.350 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2009 | 30 | 0.350 |
Why?
| Genetics, Population | 8 | 2021 | 207 | 0.340 |
Why?
| Atherosclerosis | 4 | 2022 | 345 | 0.340 |
Why?
| Linkage Disequilibrium | 12 | 2017 | 273 | 0.340 |
Why?
| Tumor Suppressor Proteins | 5 | 2016 | 289 | 0.310 |
Why?
| Veterans | 3 | 2023 | 1208 | 0.310 |
Why?
| Young Adult | 23 | 2020 | 10793 | 0.310 |
Why?
| Genetic Markers | 18 | 2017 | 348 | 0.300 |
Why?
| Adiponectin | 5 | 2011 | 226 | 0.300 |
Why?
| Alzheimer Disease | 2 | 2023 | 513 | 0.300 |
Why?
| Lipopolysaccharide Receptors | 2 | 2021 | 88 | 0.300 |
Why?
| Case-Control Studies | 16 | 2023 | 3171 | 0.290 |
Why?
| Atrial Fibrillation | 2 | 2022 | 338 | 0.290 |
Why?
| Age of Onset | 6 | 2014 | 467 | 0.280 |
Why?
| Genetic Pleiotropy | 2 | 2016 | 31 | 0.280 |
Why?
| Fibrinolysis | 1 | 2008 | 159 | 0.280 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2006 | 64 | 0.280 |
Why?
| Renal Insufficiency, Chronic | 2 | 2023 | 589 | 0.270 |
Why?
| Mutation, Missense | 7 | 2018 | 300 | 0.260 |
Why?
| Kidney | 3 | 2023 | 1353 | 0.260 |
Why?
| Chromosomes, Human, Pair 20 | 4 | 2011 | 15 | 0.260 |
Why?
| Mendelian Randomization Analysis | 2 | 2023 | 48 | 0.260 |
Why?
| Apolipoprotein L1 | 2 | 2023 | 15 | 0.260 |
Why?
| Genetic Techniques | 2 | 2004 | 60 | 0.250 |
Why?
| Inheritance Patterns | 1 | 2004 | 49 | 0.250 |
Why?
| United States | 24 | 2020 | 12555 | 0.250 |
Why?
| Fasting | 4 | 2018 | 264 | 0.240 |
Why?
| Sequence Analysis, DNA | 7 | 2016 | 755 | 0.240 |
Why?
| Blood Glucose | 6 | 2021 | 1939 | 0.240 |
Why?
| Coronary Artery Disease | 4 | 2018 | 647 | 0.240 |
Why?
| Homocysteine | 2 | 2018 | 137 | 0.240 |
Why?
| Genetics | 1 | 2004 | 28 | 0.240 |
Why?
| Prospective Studies | 14 | 2021 | 6471 | 0.230 |
Why?
| Glomerulosclerosis, Focal Segmental | 1 | 2023 | 39 | 0.230 |
Why?
| Homeodomain Proteins | 3 | 2012 | 468 | 0.230 |
Why?
| Mississippi | 3 | 2021 | 18 | 0.230 |
Why?
| Nuclear Proteins | 3 | 2014 | 597 | 0.230 |
Why?
| Chromosomes, Human, Pair 1 | 5 | 2009 | 74 | 0.220 |
Why?
| Chronic Periodontitis | 2 | 2013 | 5 | 0.220 |
Why?
| Software | 4 | 2016 | 613 | 0.220 |
Why?
| Dementia, Vascular | 1 | 2022 | 20 | 0.220 |
Why?
| Aged, 80 and over | 15 | 2020 | 6561 | 0.220 |
Why?
| Diabetic Neuropathies | 1 | 2023 | 78 | 0.220 |
Why?
| DNA, Neoplasm | 5 | 2014 | 154 | 0.220 |
Why?
| Adolescent | 28 | 2023 | 18480 | 0.210 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2022 | 107 | 0.210 |
Why?
| Polymerase Chain Reaction | 8 | 2012 | 1012 | 0.210 |
Why?
| Aging, Premature | 1 | 2021 | 11 | 0.200 |
Why?
| Cell Transformation, Neoplastic | 2 | 2020 | 317 | 0.200 |
Why?
| Chromosomes, Human, X | 3 | 2015 | 58 | 0.200 |
Why?
| Smoking | 2 | 2021 | 1487 | 0.200 |
Why?
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2012 | 35 | 0.200 |
Why?
| Age Factors | 12 | 2021 | 2995 | 0.200 |
Why?
| Risk Assessment | 11 | 2021 | 3057 | 0.200 |
Why?
| Receptors, Adiponectin | 2 | 2011 | 14 | 0.200 |
Why?
| Nutrition Surveys | 4 | 2018 | 233 | 0.190 |
Why?
| Linear Models | 4 | 2021 | 827 | 0.190 |
Why?
| Carcinoma | 3 | 2010 | 204 | 0.190 |
Why?
| Biomarkers | 7 | 2023 | 3588 | 0.190 |
Why?
| Prognosis | 9 | 2021 | 3443 | 0.190 |
Why?
| Epigenomics | 1 | 2021 | 107 | 0.190 |
Why?
| Exercise | 4 | 2016 | 1657 | 0.190 |
Why?
| Whole Genome Sequencing | 1 | 2020 | 113 | 0.180 |
Why?
| Antigens, CD | 1 | 2022 | 460 | 0.180 |
Why?
| Chemokine CXCL10 | 1 | 2020 | 40 | 0.180 |
Why?
| Factor VIII | 1 | 2020 | 56 | 0.180 |
Why?
| Zinc Fingers | 2 | 2017 | 46 | 0.180 |
Why?
| Lymphadenopathy | 1 | 2019 | 8 | 0.180 |
Why?
| Statistics, Nonparametric | 4 | 2017 | 403 | 0.180 |
Why?
| DNA-Binding Proteins | 7 | 2020 | 1346 | 0.180 |
Why?
| Genetic Testing | 4 | 2009 | 389 | 0.180 |
Why?
| Pediatric Obesity | 2 | 2017 | 524 | 0.180 |
Why?
| Adiposity | 2 | 2017 | 516 | 0.180 |
Why?
| Repressor Proteins | 3 | 2014 | 377 | 0.180 |
Why?
| Computer Simulation | 6 | 2021 | 922 | 0.170 |
Why?
| Neoplasm, Residual | 1 | 2019 | 103 | 0.170 |
Why?
| Renal Insufficiency | 1 | 2021 | 150 | 0.170 |
Why?
| Trabeculectomy | 1 | 2000 | 65 | 0.170 |
Why?
| Mortality | 1 | 2021 | 299 | 0.170 |
Why?
| International Cooperation | 5 | 2011 | 177 | 0.170 |
Why?
| Incidence | 7 | 2021 | 2424 | 0.170 |
Why?
| Epidemiologic Studies | 1 | 2019 | 58 | 0.170 |
Why?
| Lymphoma | 1 | 2020 | 180 | 0.170 |
Why?
| Mutation | 8 | 2014 | 3457 | 0.170 |
Why?
| Child | 19 | 2022 | 19129 | 0.170 |
Why?
| Cell Cycle Proteins | 4 | 2015 | 565 | 0.170 |
Why?
| Adolescent Health | 2 | 2015 | 39 | 0.170 |
Why?
| Observational Studies as Topic | 1 | 2019 | 89 | 0.160 |
Why?
| Fibrinogen | 2 | 2010 | 161 | 0.160 |
Why?
| alpha-Globins | 1 | 2018 | 12 | 0.160 |
Why?
| Hemoglobin, Sickle | 1 | 2018 | 16 | 0.160 |
Why?
| China | 2 | 2018 | 175 | 0.160 |
Why?
| Proteome | 1 | 2022 | 353 | 0.160 |
Why?
| Gene Pool | 1 | 2017 | 5 | 0.160 |
Why?
| Antithrombin III | 1 | 2017 | 7 | 0.160 |
Why?
| Thromboplastin | 2 | 2017 | 68 | 0.160 |
Why?
| Health Surveys | 2 | 2018 | 454 | 0.160 |
Why?
| Receptors, LDL | 2 | 2014 | 40 | 0.160 |
Why?
| Mitral Valve Prolapse | 1 | 2017 | 8 | 0.160 |
Why?
| Factor VIIa | 1 | 2017 | 36 | 0.160 |
Why?
| Hemoglobins, Abnormal | 1 | 2017 | 10 | 0.160 |
Why?
| Brain Ischemia | 2 | 2015 | 310 | 0.160 |
Why?
| Asthma | 5 | 2019 | 2158 | 0.150 |
Why?
| Glomerular Filtration Rate | 4 | 2023 | 683 | 0.150 |
Why?
| Leukocytes | 2 | 2016 | 290 | 0.150 |
Why?
| Body Height | 2 | 2017 | 187 | 0.150 |
Why?
| Fatty Liver | 1 | 2020 | 253 | 0.150 |
Why?
| Gene Expression | 1 | 2022 | 1489 | 0.150 |
Why?
| Blood Platelets | 2 | 2016 | 369 | 0.150 |
Why?
| Proportional Hazards Models | 6 | 2020 | 1125 | 0.150 |
Why?
| Epigenesis, Genetic | 1 | 2021 | 539 | 0.150 |
Why?
| Glaucoma | 1 | 2000 | 202 | 0.140 |
Why?
| Erythropoiesis | 1 | 2016 | 33 | 0.140 |
Why?
| Gastrointestinal Microbiome | 1 | 2023 | 548 | 0.140 |
Why?
| Interferon-gamma | 1 | 2020 | 736 | 0.140 |
Why?
| Cadmium | 1 | 2016 | 62 | 0.140 |
Why?
| Immune System Diseases | 1 | 2016 | 35 | 0.140 |
Why?
| Antihypertensive Agents | 1 | 2020 | 437 | 0.140 |
Why?
| Insulin-Like Growth Factor I | 2 | 2009 | 287 | 0.140 |
Why?
| Chromosomes, Human, Y | 1 | 2015 | 15 | 0.140 |
Why?
| Factor XII | 1 | 2015 | 5 | 0.140 |
Why?
| Microbiota | 1 | 2023 | 656 | 0.140 |
Why?
| Cross-Sectional Studies | 8 | 2021 | 4552 | 0.140 |
Why?
| Schizophrenia | 5 | 2007 | 501 | 0.140 |
Why?
| Algorithms | 3 | 2021 | 1541 | 0.140 |
Why?
| Receptors, Neurokinin-3 | 1 | 2015 | 6 | 0.140 |
Why?
| Disease | 1 | 2016 | 98 | 0.130 |
Why?
| Cholesterol, LDL | 2 | 2014 | 316 | 0.130 |
Why?
| Immunotherapy | 1 | 2019 | 493 | 0.130 |
Why?
| Laminin | 1 | 2015 | 68 | 0.130 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2015 | 71 | 0.130 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 770 | 0.130 |
Why?
| Menarche | 1 | 2015 | 51 | 0.130 |
Why?
| Energy Metabolism | 2 | 2017 | 767 | 0.130 |
Why?
| Calcium-Binding Proteins | 2 | 2013 | 217 | 0.130 |
Why?
| Motor Activity | 2 | 2013 | 660 | 0.130 |
Why?
| Chromosomes, Human, Pair 5 | 2 | 2012 | 26 | 0.130 |
Why?
| Mutation Rate | 1 | 2015 | 25 | 0.130 |
Why?
| Chromosomes, Human, Pair 12 | 2 | 2019 | 28 | 0.130 |
Why?
| Apolipoproteins A | 1 | 2014 | 18 | 0.130 |
Why?
| Immunoglobulins | 1 | 2015 | 154 | 0.130 |
Why?
| Gene-Environment Interaction | 1 | 2016 | 201 | 0.130 |
Why?
| Energy Intake | 1 | 2017 | 447 | 0.130 |
Why?
| Epistasis, Genetic | 1 | 2015 | 73 | 0.130 |
Why?
| Membrane Proteins | 3 | 2016 | 1055 | 0.130 |
Why?
| Anemia, Sickle Cell | 1 | 2018 | 230 | 0.130 |
Why?
| Africa | 2 | 2020 | 100 | 0.130 |
Why?
| Thrombin | 1 | 2015 | 143 | 0.130 |
Why?
| DNA, Mitochondrial | 1 | 2015 | 187 | 0.120 |
Why?
| Insulin Resistance | 2 | 2021 | 1180 | 0.120 |
Why?
| CD36 Antigens | 1 | 2014 | 42 | 0.120 |
Why?
| Residence Characteristics | 1 | 2016 | 299 | 0.120 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 1390 | 0.120 |
Why?
| AMP-Activated Protein Kinases | 1 | 2015 | 178 | 0.120 |
Why?
| CARD Signaling Adaptor Proteins | 1 | 2013 | 17 | 0.120 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2013 | 28 | 0.120 |
Why?
| Penetrance | 2 | 2015 | 27 | 0.120 |
Why?
| RNA, Long Noncoding | 1 | 2016 | 161 | 0.120 |
Why?
| Diabetes, Gestational | 1 | 2017 | 283 | 0.120 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 394 | 0.120 |
Why?
| Philippines | 5 | 2011 | 55 | 0.120 |
Why?
| Blood Cells | 1 | 2012 | 39 | 0.110 |
Why?
| Periodontium | 1 | 2012 | 2 | 0.110 |
Why?
| Meta-Analysis as Topic | 4 | 2014 | 164 | 0.110 |
Why?
| Time Factors | 6 | 2021 | 6412 | 0.110 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2019 | 532 | 0.110 |
Why?
| Autoantigens | 1 | 2015 | 397 | 0.110 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 256 | 0.110 |
Why?
| Promoter Regions, Genetic | 3 | 2006 | 1158 | 0.110 |
Why?
| Glutathione Transferase | 1 | 2012 | 97 | 0.110 |
Why?
| RNA-Binding Proteins | 1 | 2015 | 371 | 0.110 |
Why?
| Arsenic | 1 | 2012 | 40 | 0.110 |
Why?
| Interleukin-18 | 1 | 2013 | 228 | 0.110 |
Why?
| Methyltransferases | 1 | 2012 | 61 | 0.100 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2017 | 468 | 0.100 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2011 | 29 | 0.100 |
Why?
| Factor VII | 1 | 2011 | 24 | 0.100 |
Why?
| Metagenome | 1 | 2012 | 121 | 0.100 |
Why?
| Logistic Models | 3 | 2012 | 1901 | 0.100 |
Why?
| Sample Size | 3 | 2021 | 133 | 0.100 |
Why?
| Chromosomes, Human, Pair 22 | 2 | 2010 | 39 | 0.100 |
Why?
| Kininogen, Low-Molecular-Weight | 1 | 2010 | 2 | 0.100 |
Why?
| Kininogens | 1 | 2010 | 4 | 0.100 |
Why?
| Kininogen, High-Molecular-Weight | 1 | 2010 | 3 | 0.100 |
Why?
| Homozygote | 3 | 2012 | 190 | 0.100 |
Why?
| Erythrocytes | 1 | 2016 | 641 | 0.100 |
Why?
| Mathematical Computing | 1 | 2010 | 13 | 0.100 |
Why?
| Cystic Fibrosis | 2 | 2011 | 964 | 0.100 |
Why?
| Family | 4 | 2006 | 585 | 0.100 |
Why?
| Indians, North American | 1 | 2016 | 598 | 0.100 |
Why?
| TCF Transcription Factors | 1 | 2010 | 21 | 0.090 |
Why?
| Nandrolone | 1 | 2010 | 2 | 0.090 |
Why?
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2010 | 6 | 0.090 |
Why?
| Ethinyl Estradiol | 1 | 2010 | 17 | 0.090 |
Why?
| Malawi | 1 | 2010 | 50 | 0.090 |
Why?
| Population | 1 | 2010 | 30 | 0.090 |
Why?
| Contraceptives, Oral, Hormonal | 1 | 2010 | 23 | 0.090 |
Why?
| Molecular Epidemiology | 2 | 2022 | 69 | 0.090 |
Why?
| Carbohydrate Metabolism | 1 | 2010 | 50 | 0.090 |
Why?
| RNA Helicases | 1 | 2009 | 20 | 0.090 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 3 | 2016 | 23 | 0.090 |
Why?
| Heterozygote | 3 | 2016 | 262 | 0.090 |
Why?
| Peptidyl-Dipeptidase A | 2 | 2009 | 56 | 0.090 |
Why?
| Heart Failure | 1 | 2022 | 1969 | 0.090 |
Why?
| Urinary Bladder Neoplasms | 1 | 2012 | 211 | 0.090 |
Why?
| Multifactorial Inheritance | 2 | 2023 | 143 | 0.090 |
Why?
| WW Domain-Containing Oxidoreductase | 1 | 2009 | 2 | 0.090 |
Why?
| Myocardial Infarction | 2 | 2014 | 968 | 0.090 |
Why?
| Cadherins | 1 | 2010 | 186 | 0.090 |
Why?
| Maxilla | 1 | 2009 | 29 | 0.090 |
Why?
| Cephalometry | 1 | 2009 | 28 | 0.090 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2009 | 51 | 0.090 |
Why?
| Genes, Recessive | 4 | 2004 | 73 | 0.080 |
Why?
| Collagen Type II | 1 | 2009 | 48 | 0.080 |
Why?
| Glucose Intolerance | 1 | 2010 | 139 | 0.080 |
Why?
| Genes, Homeobox | 1 | 2009 | 51 | 0.080 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 87 | 0.080 |
Why?
| Prostate-Specific Antigen | 2 | 2007 | 156 | 0.080 |
Why?
| Stroke | 2 | 2015 | 1047 | 0.080 |
Why?
| Psoriasis | 2 | 2002 | 76 | 0.080 |
Why?
| Oxidoreductases | 1 | 2009 | 100 | 0.080 |
Why?
| Adolescent Behavior | 1 | 2013 | 482 | 0.080 |
Why?
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 9 | 0.080 |
Why?
| Environmental Exposure | 1 | 2012 | 405 | 0.080 |
Why?
| alpha 1-Antitrypsin | 1 | 2009 | 115 | 0.080 |
Why?
| Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 22 | 0.080 |
Why?
| Urokinase-Type Plasminogen Activator | 1 | 2008 | 30 | 0.080 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2020 | 101 | 0.080 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 82 | 0.080 |
Why?
| Interleukin-6 | 2 | 2009 | 688 | 0.080 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2008 | 111 | 0.080 |
Why?
| HLA-DR2 Antigen | 1 | 2007 | 8 | 0.080 |
Why?
| Prediabetic State | 1 | 2010 | 234 | 0.080 |
Why?
| Germany | 3 | 2020 | 89 | 0.080 |
Why?
| Genes, Dominant | 2 | 2004 | 96 | 0.080 |
Why?
| BRCA1 Protein | 1 | 2007 | 57 | 0.070 |
Why?
| HLA-DR3 Antigen | 1 | 2007 | 77 | 0.070 |
Why?
| Europe | 1 | 2008 | 356 | 0.070 |
Why?
| Neural Cell Adhesion Molecules | 1 | 2006 | 24 | 0.070 |
Why?
| Breast Neoplasms | 3 | 2004 | 1965 | 0.070 |
Why?
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 453 | 0.070 |
Why?
| DNA Methylation | 2 | 2021 | 503 | 0.070 |
Why?
| Liver Diseases | 1 | 2009 | 282 | 0.070 |
Why?
| Prostatic Intraepithelial Neoplasia | 1 | 2006 | 12 | 0.070 |
Why?
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2006 | 12 | 0.070 |
Why?
| Sex Factors | 5 | 2017 | 1781 | 0.070 |
Why?
| Mixed Function Oxygenases | 1 | 2006 | 37 | 0.070 |
Why?
| Infant | 5 | 2010 | 8293 | 0.070 |
Why?
| Genes, Lethal | 1 | 2005 | 25 | 0.070 |
Why?
| Transcription Factors | 3 | 2012 | 1570 | 0.070 |
Why?
| Pimozide | 2 | 1976 | 3 | 0.070 |
Why?
| Genomic Imprinting | 1 | 2005 | 32 | 0.070 |
Why?
| Follow-Up Studies | 4 | 2014 | 4596 | 0.070 |
Why?
| Genomics | 2 | 2007 | 706 | 0.070 |
Why?
| National Longitudinal Study of Adolescent Health | 2 | 2016 | 7 | 0.070 |
Why?
| Chromosomes | 1 | 2005 | 87 | 0.070 |
Why?
| Warfarin | 1 | 2006 | 139 | 0.070 |
Why?
| Kaplan-Meier Estimate | 2 | 2019 | 842 | 0.070 |
Why?
| Multigene Family | 1 | 2005 | 200 | 0.060 |
Why?
| Serum | 1 | 2005 | 63 | 0.060 |
Why?
| Platelet Count | 2 | 2016 | 83 | 0.060 |
Why?
| Fertility | 1 | 2005 | 135 | 0.060 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2007 | 227 | 0.060 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 420 | 0.060 |
Why?
| Hematocrit | 2 | 2016 | 91 | 0.060 |
Why?
| Immunoglobulin E | 2 | 2003 | 365 | 0.060 |
Why?
| Receptor, Melanocortin, Type 4 | 2 | 2016 | 11 | 0.060 |
Why?
| Survival Analysis | 2 | 2020 | 1267 | 0.060 |
Why?
| Neoplasm Invasiveness | 1 | 2006 | 462 | 0.060 |
Why?
| Lung Diseases | 1 | 2011 | 718 | 0.060 |
Why?
| Siblings | 3 | 2010 | 235 | 0.060 |
Why?
| Michigan | 3 | 2012 | 95 | 0.060 |
Why?
| Physical Fitness | 1 | 2005 | 179 | 0.060 |
Why?
| Apolipoproteins | 1 | 2023 | 39 | 0.060 |
Why?
| Meiosis | 1 | 2004 | 60 | 0.060 |
Why?
| Syndrome | 3 | 2017 | 344 | 0.060 |
Why?
| Insulin | 4 | 2021 | 2162 | 0.060 |
Why?
| Intermediate Filaments | 1 | 2023 | 46 | 0.060 |
Why?
| Neurofilament Proteins | 1 | 2023 | 33 | 0.060 |
Why?
| Hypersensitivity, Immediate | 1 | 2003 | 59 | 0.060 |
Why?
| Societies, Medical | 1 | 2007 | 703 | 0.060 |
Why?
| Pilot Projects | 2 | 2022 | 1419 | 0.060 |
Why?
| Asialoglycoprotein Receptor | 1 | 2022 | 4 | 0.060 |
Why?
| Tropomyosin | 1 | 2002 | 13 | 0.060 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2003 | 127 | 0.060 |
Why?
| Endoribonucleases | 1 | 2003 | 64 | 0.060 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2022 | 55 | 0.050 |
Why?
| Disease Progression | 2 | 2020 | 2490 | 0.050 |
Why?
| Osteoarthritis, Knee | 1 | 2005 | 223 | 0.050 |
Why?
| Inflammation | 2 | 2013 | 2566 | 0.050 |
Why?
| Hemoglobins | 2 | 2016 | 326 | 0.050 |
Why?
| Cognition Disorders | 1 | 2007 | 529 | 0.050 |
Why?
| Receptors, Immunologic | 1 | 2003 | 209 | 0.050 |
Why?
| Genome | 1 | 2004 | 277 | 0.050 |
Why?
| Risk | 3 | 2010 | 853 | 0.050 |
Why?
| Anticoagulants | 1 | 2006 | 559 | 0.050 |
Why?
| Biomarkers, Tumor | 2 | 2006 | 1059 | 0.050 |
Why?
| Adenocarcinoma | 1 | 2008 | 812 | 0.050 |
Why?
| Data Interpretation, Statistical | 2 | 2015 | 336 | 0.050 |
Why?
| Causality | 1 | 2021 | 109 | 0.050 |
Why?
| CpG Islands | 1 | 2021 | 119 | 0.050 |
Why?
| alpha Karyopherins | 1 | 2020 | 15 | 0.050 |
Why?
| Platelet Factor 4 | 1 | 1980 | 22 | 0.050 |
Why?
| HLA Antigens | 1 | 2002 | 230 | 0.050 |
Why?
| Tripartite Motif Proteins | 1 | 2020 | 31 | 0.050 |
Why?
| Drosophila Proteins | 1 | 2002 | 171 | 0.050 |
Why?
| Dioxygenases | 1 | 2020 | 26 | 0.050 |
Why?
| Mitogens | 1 | 1980 | 57 | 0.050 |
Why?
| Kidney Function Tests | 1 | 2021 | 164 | 0.050 |
Why?
| Blood Coagulation Factors | 1 | 1980 | 43 | 0.050 |
Why?
| Growth Substances | 1 | 1980 | 136 | 0.050 |
Why?
| Codon, Nonsense | 2 | 2015 | 38 | 0.050 |
Why?
| Disease Susceptibility | 4 | 2009 | 331 | 0.050 |
Why?
| Cell Self Renewal | 1 | 2020 | 51 | 0.050 |
Why?
| Cell Adhesion Molecules | 2 | 2017 | 180 | 0.050 |
Why?
| Africa, Western | 1 | 2020 | 17 | 0.050 |
Why?
| DNA Mutational Analysis | 2 | 2016 | 381 | 0.050 |
Why?
| Tobacco Smoke Pollution | 1 | 2003 | 233 | 0.050 |
Why?
| Body Weight | 3 | 2010 | 934 | 0.050 |
Why?
| Carotid Intima-Media Thickness | 1 | 2020 | 68 | 0.050 |
Why?
| von Willebrand Factor | 1 | 2020 | 58 | 0.050 |
Why?
| Diabetic Nephropathies | 1 | 2003 | 289 | 0.040 |
Why?
| Albuminuria | 1 | 2020 | 195 | 0.040 |
Why?
| Models, Statistical | 1 | 2004 | 636 | 0.040 |
Why?
| Exons | 3 | 2006 | 307 | 0.040 |
Why?
| Bayes Theorem | 2 | 2016 | 344 | 0.040 |
Why?
| Autoantibodies | 1 | 2007 | 1335 | 0.040 |
Why?
| Idarubicin | 1 | 2019 | 3 | 0.040 |
Why?
| Cognition | 1 | 2006 | 1024 | 0.040 |
Why?
| Infant, Newborn | 3 | 2017 | 5255 | 0.040 |
Why?
| Neoplasm Grading | 1 | 2020 | 258 | 0.040 |
Why?
| Calcinosis | 1 | 2002 | 282 | 0.040 |
Why?
| Abdomen | 1 | 2019 | 110 | 0.040 |
Why?
| Induction Chemotherapy | 1 | 2019 | 59 | 0.040 |
Why?
| Brain | 3 | 2007 | 2490 | 0.040 |
Why?
| Creatinine | 1 | 2020 | 491 | 0.040 |
Why?
| Etoposide | 1 | 2019 | 149 | 0.040 |
Why?
| Chromosome Breakage | 1 | 1998 | 20 | 0.040 |
Why?
| Pregnancy | 3 | 2021 | 5690 | 0.040 |
Why?
| alpha-Thalassemia | 1 | 2018 | 4 | 0.040 |
Why?
| Erythrocytes, Abnormal | 1 | 2018 | 16 | 0.040 |
Why?
| Treatment Outcome | 3 | 2019 | 9342 | 0.040 |
Why?
| Prostate | 2 | 2012 | 158 | 0.040 |
Why?
| Endothelial Protein C Receptor | 1 | 2017 | 5 | 0.040 |
Why?
| Azacitidine | 1 | 2019 | 119 | 0.040 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2017 | 3 | 0.040 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 404 | 0.040 |
Why?
| Disease-Free Survival | 1 | 2019 | 649 | 0.040 |
Why?
| Research Design | 1 | 2004 | 969 | 0.040 |
Why?
| Amino Acid Substitution | 2 | 2012 | 276 | 0.040 |
Why?
| Intraocular Pressure | 1 | 2000 | 275 | 0.040 |
Why?
| Kidney Failure, Chronic | 1 | 2003 | 516 | 0.040 |
Why?
| Homeostasis | 1 | 2021 | 594 | 0.040 |
Why?
| Cytokines | 1 | 2005 | 1900 | 0.040 |
Why?
| Hematopoietic Stem Cells | 1 | 2020 | 359 | 0.040 |
Why?
| Procollagen N-Endopeptidase | 1 | 2017 | 7 | 0.040 |
Why?
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 3 | 0.040 |
Why?
| ADAMTS Proteins | 1 | 2017 | 6 | 0.040 |
Why?
| NADPH Oxidase 4 | 1 | 2017 | 10 | 0.040 |
Why?
| Somatomedins | 1 | 2017 | 27 | 0.040 |
Why?
| Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 14 | 0.040 |
Why?
| DNA Copy Number Variations | 1 | 2018 | 167 | 0.040 |
Why?
| DNA | 2 | 2022 | 1388 | 0.040 |
Why?
| Mitochondrial Membrane Transport Proteins | 1 | 2016 | 31 | 0.040 |
Why?
| Body Burden | 1 | 2016 | 5 | 0.040 |
Why?
| Interferon Regulatory Factors | 1 | 2017 | 31 | 0.040 |
Why?
| Proto-Oncogene Proteins | 1 | 2020 | 618 | 0.040 |
Why?
| Autopsy | 1 | 1997 | 89 | 0.040 |
Why?
| Lymph Nodes | 1 | 2019 | 455 | 0.040 |
Why?
| Muridae | 1 | 1996 | 4 | 0.040 |
Why?
| Mean Platelet Volume | 1 | 2016 | 3 | 0.040 |
Why?
| Statistics as Topic | 1 | 2017 | 307 | 0.040 |
Why?
| Precision Medicine | 1 | 2020 | 363 | 0.040 |
Why?
| Allelic Imbalance | 1 | 2016 | 7 | 0.040 |
Why?
| Transcription Factor AP-2 | 1 | 2016 | 81 | 0.040 |
Why?
| Erythrocyte Indices | 1 | 2016 | 29 | 0.040 |
Why?
| Transportation | 1 | 2016 | 42 | 0.040 |
Why?
| Glycosaminoglycans | 1 | 2017 | 78 | 0.040 |
Why?
| Geographic Information Systems | 1 | 2016 | 40 | 0.040 |
Why?
| Drosophila | 1 | 2017 | 140 | 0.040 |
Why?
| NADPH Oxidases | 1 | 2017 | 138 | 0.040 |
Why?
| Blood Cell Count | 1 | 2016 | 53 | 0.040 |
Why?
| Proteoglycans | 1 | 2017 | 109 | 0.040 |
Why?
| Proteolysis | 1 | 2017 | 146 | 0.040 |
Why?
| Parents | 1 | 2004 | 1212 | 0.040 |
Why?
| Homicide | 1 | 1997 | 53 | 0.040 |
Why?
| Neoplasm Staging | 1 | 2020 | 1223 | 0.040 |
Why?
| Biopsy | 1 | 2020 | 1079 | 0.030 |
Why?
| Glucose | 1 | 2021 | 953 | 0.030 |
Why?
| Quality Control | 1 | 2016 | 159 | 0.030 |
Why?
| Chromosomes, Human | 2 | 2009 | 41 | 0.030 |
Why?
| Electrocardiography | 1 | 2019 | 556 | 0.030 |
Why?
| Area Under Curve | 1 | 2016 | 296 | 0.030 |
Why?
| Diet | 1 | 2023 | 1153 | 0.030 |
Why?
| Adipose Tissue | 1 | 2020 | 606 | 0.030 |
Why?
| Genes, X-Linked | 1 | 2015 | 17 | 0.030 |
Why?
| Hedgehog Proteins | 1 | 2017 | 175 | 0.030 |
Why?
| Prevalence | 2 | 2013 | 2326 | 0.030 |
Why?
| Gene Expression Regulation | 2 | 2021 | 2445 | 0.030 |
Why?
| Normal Distribution | 1 | 2015 | 24 | 0.030 |
Why?
| Glucose-6-Phosphatase | 1 | 2015 | 32 | 0.030 |
Why?
| Apolipoprotein A-V | 1 | 2014 | 3 | 0.030 |
Why?
| Hypogonadism | 1 | 2015 | 77 | 0.030 |
Why?
| Glycoproteins | 1 | 2017 | 319 | 0.030 |
Why?
| Amides | 1 | 2015 | 86 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 473 | 0.030 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 369 | 0.030 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 1995 | 35 | 0.030 |
Why?
| Echocardiography | 1 | 2017 | 556 | 0.030 |
Why?
| Circadian Rhythm | 1 | 2018 | 401 | 0.030 |
Why?
| Birth Weight | 1 | 2017 | 465 | 0.030 |
Why?
| Population Surveillance | 1 | 2018 | 413 | 0.030 |
Why?
| Environment | 1 | 2016 | 346 | 0.030 |
Why?
| Age Distribution | 1 | 2015 | 362 | 0.030 |
Why?
| Child, Preschool | 4 | 2009 | 9491 | 0.030 |
Why?
| Sex Distribution | 1 | 2015 | 351 | 0.030 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 75 | 0.030 |
Why?
| Molecular Sequence Data | 3 | 2012 | 2871 | 0.030 |
Why?
| Mothers | 2 | 2010 | 682 | 0.030 |
Why?
| Genetic Code | 1 | 2014 | 20 | 0.030 |
Why?
| Proprotein Convertases | 1 | 2014 | 14 | 0.030 |
Why?
| Proprotein Convertase 9 | 1 | 2014 | 60 | 0.030 |
Why?
| Amino Acid Sequence | 2 | 2012 | 2071 | 0.030 |
Why?
| Lipase | 1 | 2014 | 70 | 0.030 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 1993 | 36 | 0.030 |
Why?
| Serine Endopeptidases | 1 | 2014 | 105 | 0.030 |
Why?
| Video Games | 1 | 2013 | 22 | 0.030 |
Why?
| RNA Interference | 1 | 2015 | 460 | 0.030 |
Why?
| Hexosyltransferases | 1 | 2012 | 5 | 0.030 |
Why?
| Television | 1 | 2013 | 71 | 0.030 |
Why?
| Ambulatory Care | 2 | 1976 | 482 | 0.030 |
Why?
| International Agencies | 1 | 2012 | 29 | 0.030 |
Why?
| Confidence Intervals | 2 | 2003 | 324 | 0.030 |
Why?
| Prevotella nigrescens | 1 | 2012 | 1 | 0.030 |
Why?
| Vesicle-Associated Membrane Protein 3 | 1 | 2012 | 2 | 0.030 |
Why?
| Prevotella intermedia | 1 | 2012 | 2 | 0.030 |
Why?
| Campylobacter rectus | 1 | 2012 | 2 | 0.030 |
Why?
| Treponema denticola | 1 | 2012 | 2 | 0.030 |
Why?
| Fusobacterium nucleatum | 1 | 2012 | 3 | 0.030 |
Why?
| Porphyromonas gingivalis | 1 | 2012 | 15 | 0.030 |
Why?
| Bacteroides | 1 | 2012 | 18 | 0.030 |
Why?
| Aggregatibacter actinomycetemcomitans | 1 | 2012 | 19 | 0.030 |
Why?
| Potassium Channels, Tandem Pore Domain | 1 | 2012 | 11 | 0.030 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 52 | 0.030 |
Why?
| Fatty Acids | 1 | 2015 | 407 | 0.030 |
Why?
| F-Box Proteins | 1 | 2012 | 20 | 0.030 |
Why?
| Hematologic Diseases | 1 | 2012 | 60 | 0.030 |
Why?
| Triglycerides | 1 | 2014 | 519 | 0.030 |
Why?
| Bacterial Load | 1 | 2012 | 61 | 0.030 |
Why?
| Interleukin-33 | 1 | 2012 | 39 | 0.030 |
Why?
| Nuclear Family | 2 | 2003 | 54 | 0.030 |
Why?
| Fetal Diseases | 1 | 1993 | 148 | 0.030 |
Why?
| Principal Component Analysis | 1 | 2012 | 180 | 0.030 |
Why?
| Dyslipidemias | 1 | 2014 | 162 | 0.030 |
Why?
| Nucleic Acid Hybridization | 1 | 2012 | 193 | 0.030 |
Why?
| Neuropsychological Tests | 2 | 2007 | 1032 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2012 | 372 | 0.030 |
Why?
| Prenatal Diagnosis | 1 | 1993 | 168 | 0.030 |
Why?
| Islets of Langerhans | 1 | 2018 | 739 | 0.030 |
Why?
| Crosses, Genetic | 2 | 2005 | 138 | 0.030 |
Why?
| Liver | 1 | 2020 | 1816 | 0.030 |
Why?
| DNA Primers | 1 | 2012 | 533 | 0.030 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2012 | 148 | 0.020 |
Why?
| Finland | 2 | 2001 | 71 | 0.020 |
Why?
| Southeastern United States | 1 | 2010 | 31 | 0.020 |
Why?
| Drinking Water | 1 | 2012 | 68 | 0.020 |
Why?
| DNA, Bacterial | 1 | 2012 | 314 | 0.020 |
Why?
| Signal Transduction | 2 | 2015 | 4709 | 0.020 |
Why?
| Recombination, Genetic | 3 | 1998 | 173 | 0.020 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2010 | 24 | 0.020 |
Why?
| Interleukins | 1 | 2012 | 242 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2013 | 408 | 0.020 |
Why?
| Hypertriglyceridemia | 1 | 2010 | 39 | 0.020 |
Why?
| Waist Circumference | 1 | 2010 | 130 | 0.020 |
Why?
| Menstruation | 1 | 2010 | 36 | 0.020 |
Why?
| Fanconi Anemia Complementation Group Proteins | 1 | 2009 | 9 | 0.020 |
Why?
| Glutathione S-Transferase pi | 1 | 2009 | 8 | 0.020 |
Why?
| Mannose-Binding Lectin | 1 | 2009 | 21 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2014 | 1691 | 0.020 |
Why?
| Trans-Activators | 1 | 2012 | 373 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2012 | 502 | 0.020 |
Why?
| Animals | 6 | 2017 | 33381 | 0.020 |
Why?
| C-Peptide | 1 | 2010 | 137 | 0.020 |
Why?
| Hypertension, Portal | 1 | 2009 | 67 | 0.020 |
Why?
| Twins | 1 | 2010 | 247 | 0.020 |
Why?
| Body Composition | 1 | 2013 | 653 | 0.020 |
Why?
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2009 | 40 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2012 | 1474 | 0.020 |
Why?
| Glucose Tolerance Test | 1 | 2010 | 368 | 0.020 |
Why?
| Fanconi Anemia Complementation Group N Protein | 1 | 2008 | 5 | 0.020 |
Why?
| Transforming Growth Factor beta1 | 1 | 2009 | 164 | 0.020 |
Why?
| Interviews as Topic | 1 | 2011 | 599 | 0.020 |
Why?
| Educational Status | 1 | 2010 | 437 | 0.020 |
Why?
| Puberty | 1 | 2009 | 144 | 0.020 |
Why?
| Nutritional Status | 1 | 2010 | 300 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2008 | 38 | 0.020 |
Why?
| Intracranial Arteriosclerosis | 2 | 2006 | 8 | 0.020 |
Why?
| Fathers | 1 | 2008 | 47 | 0.020 |
Why?
| Longevity | 1 | 2009 | 151 | 0.020 |
Why?
| Liver Cirrhosis | 1 | 2009 | 245 | 0.020 |
Why?
| Monte Carlo Method | 2 | 2002 | 146 | 0.020 |
Why?
| Isoenzymes | 1 | 2008 | 297 | 0.020 |
Why?
| Tunica Intima | 1 | 2006 | 78 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 1996 | 4908 | 0.020 |
Why?
| Vitamin K Epoxide Reductases | 1 | 2006 | 12 | 0.020 |
Why?
| Cytochrome P-450 CYP2C9 | 1 | 2006 | 18 | 0.020 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2006 | 7 | 0.020 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2006 | 10 | 0.020 |
Why?
| Genetic Heterogeneity | 1 | 2006 | 56 | 0.020 |
Why?
| International Normalized Ratio | 1 | 2006 | 45 | 0.020 |
Why?
| Sweden | 1 | 2006 | 63 | 0.020 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 43 | 0.020 |
Why?
| Embolism | 1 | 2006 | 43 | 0.020 |
Why?
| Weight Lifting | 1 | 2005 | 30 | 0.020 |
Why?
| Arterial Occlusive Diseases | 1 | 2006 | 74 | 0.020 |
Why?
| Carotid Arteries | 1 | 2006 | 184 | 0.020 |
Why?
| DNA Probes | 2 | 1997 | 60 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 76 | 0.020 |
Why?
| Mice, Inbred Strains | 1 | 2005 | 405 | 0.020 |
Why?
| DNA Replication | 1 | 2006 | 211 | 0.020 |
Why?
| Statistical Distributions | 1 | 2004 | 8 | 0.020 |
Why?
| Adult Children | 1 | 2003 | 18 | 0.020 |
Why?
| Scavenger Receptors, Class A | 1 | 2003 | 9 | 0.010 |
Why?
| Likelihood Functions | 1 | 2003 | 136 | 0.010 |
Why?
| Receptors, Scavenger | 1 | 2003 | 17 | 0.010 |
Why?
| Consanguinity | 2 | 1994 | 49 | 0.010 |
Why?
| Analysis of Variance | 1 | 2006 | 1293 | 0.010 |
Why?
| Systole | 1 | 2003 | 168 | 0.010 |
Why?
| Minisatellite Repeats | 1 | 2003 | 38 | 0.010 |
Why?
| Skin Tests | 1 | 2003 | 135 | 0.010 |
Why?
| X-ray Repair Cross Complementing Protein 1 | 1 | 2003 | 16 | 0.010 |
Why?
| Radiography | 1 | 2006 | 861 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 64 | 0.010 |
Why?
| Mice | 4 | 2005 | 15520 | 0.010 |
Why?
| 3' Untranslated Regions | 1 | 2003 | 142 | 0.010 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2004 | 490 | 0.010 |
Why?
| Heart Diseases | 1 | 2006 | 341 | 0.010 |
Why?
| RNA, Neoplasm | 1 | 2002 | 77 | 0.010 |
Why?
| Cell Line | 2 | 2002 | 2707 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2010 | 2874 | 0.010 |
Why?
| Transduction, Genetic | 1 | 2002 | 116 | 0.010 |
Why?
| Depressive Disorder, Major | 2 | 1976 | 303 | 0.010 |
Why?
| Reference Values | 1 | 2003 | 774 | 0.010 |
Why?
| Phylogeny | 1 | 2005 | 816 | 0.010 |
Why?
| Walking | 1 | 2005 | 415 | 0.010 |
Why?
| Isoelectric Point | 1 | 1980 | 23 | 0.010 |
Why?
| Matched-Pair Analysis | 1 | 2000 | 39 | 0.010 |
Why?
| Base Sequence | 2 | 1995 | 2159 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 2002 | 874 | 0.010 |
Why?
| Cell Division | 1 | 2002 | 776 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2005 | 1171 | 0.010 |
Why?
| Biological Assay | 1 | 1980 | 122 | 0.010 |
Why?
| Cyclothymic Disorder | 2 | 1976 | 3 | 0.010 |
Why?
| Renal Dialysis | 1 | 2003 | 378 | 0.010 |
Why?
| Ovarian Neoplasms | 1 | 2004 | 420 | 0.010 |
Why?
| Internet | 1 | 2004 | 633 | 0.010 |
Why?
| Kinetics | 1 | 2002 | 1624 | 0.010 |
Why?
| Aging | 1 | 2009 | 1670 | 0.010 |
Why?
| Founder Effect | 1 | 1998 | 12 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2006 | 2674 | 0.010 |
Why?
| Depression | 2 | 1976 | 1132 | 0.010 |
Why?
| Death Certificates | 1 | 1997 | 28 | 0.010 |
Why?
| Accidents | 1 | 1997 | 44 | 0.010 |
Why?
| Malpractice | 1 | 1997 | 38 | 0.010 |
Why?
| Dibenzocycloheptenes | 1 | 1976 | 2 | 0.010 |
Why?
| Fluspirilene | 1 | 1976 | 1 | 0.010 |
Why?
| Penfluridol | 1 | 1976 | 1 | 0.010 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 1996 | 62 | 0.010 |
Why?
| Fluphenazine | 1 | 1976 | 5 | 0.010 |
Why?
| Therapeutic Equivalency | 1 | 1976 | 18 | 0.010 |
Why?
| Nail-Patella Syndrome | 1 | 1976 | 1 | 0.010 |
Why?
| Remission, Spontaneous | 1 | 1976 | 37 | 0.010 |
Why?
| Haloperidol | 1 | 1976 | 36 | 0.010 |
Why?
| ABO Blood-Group System | 1 | 1976 | 35 | 0.010 |
Why?
| Costa Rica | 1 | 1995 | 19 | 0.010 |
Why?
| Diagnostic Errors | 1 | 1997 | 162 | 0.010 |
Why?
| Paranoid Disorders | 1 | 1975 | 3 | 0.010 |
Why?
| Hallucinations | 1 | 1975 | 29 | 0.010 |
Why?
| Cause of Death | 1 | 1997 | 380 | 0.010 |
Why?
| Long-Term Care | 1 | 1975 | 74 | 0.010 |
Why?
| Genes | 1 | 1995 | 231 | 0.010 |
Why?
| Delayed-Action Preparations | 1 | 1975 | 161 | 0.010 |
Why?
| Hybrid Cells | 1 | 1993 | 46 | 0.010 |
Why?
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 1993 | 15 | 0.010 |
Why?
| DNA, Complementary | 1 | 1993 | 268 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1993 | 311 | 0.010 |
Why?
| Turkey | 1 | 1992 | 15 | 0.010 |
Why?
| Chromosome Banding | 1 | 1992 | 18 | 0.010 |
Why?
| Cells, Cultured | 1 | 1980 | 4077 | 0.010 |
Why?
| Blotting, Southern | 1 | 1992 | 67 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2002 | 2436 | 0.010 |
Why?
| Ataxia | 1 | 1992 | 38 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 1975 | 965 | 0.010 |
Why?
| Microcephaly | 1 | 1992 | 54 | 0.010 |
Why?
| Suicide | 1 | 1997 | 500 | 0.010 |
Why?
| Retrospective Studies | 1 | 2006 | 12978 | 0.010 |
Why?
| Cysticercosis | 1 | 1969 | 4 | 0.010 |
Why?
| Cataract | 1 | 1992 | 194 | 0.010 |
Why?
| Wounds and Injuries | 1 | 1997 | 772 | 0.010 |
Why?
| Diagnosis, Differential | 1 | 1992 | 1384 | 0.000 |
Why?
| Brain Diseases | 1 | 1969 | 140 | 0.000 |
Why?
| Adjustment Disorders | 1 | 1976 | 5 | 0.000 |
Why?
| Psychophysiologic Disorders | 1 | 1976 | 11 | 0.000 |
Why?
| Neurocognitive Disorders | 1 | 1976 | 25 | 0.000 |
Why?
| Computers | 1 | 1976 | 64 | 0.000 |
Why?
|
|
Lange's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|